News

The Shanghai Canbi news column provides information on reference preparations, pharmaceutical intermediates, development of pharmaceutical raw materials and blood products in the field of biomedicine. Access to the latest and most comprehensive medical news policies through various global medical news platforms, collect the latest medical research and development data, take you to understand the latest trends and policies of the pharmaceutical industry, stay at home to read the latest global medical news and information.

• 
  New Ponemon Institute Research Shows Ransomware Attacks on Healthcare Delivery Organizations Can Lead to Increased Mortality Rate
  BOSTON--(BUSINESS WIRE)--Ponemon Institute, the pre-eminent research center dedicated to privacy, data protection, and information security policy, surveyed 597 IT and IT security professionals to understand how COVID-19 has impacted how healthcare delive
  Tags：
  The number of readers：993
  Source：
  2021-09-22
• 
  Moderna Highlights New Clinical Data on its COVID-19 Vaccine
  CAMBRIDGE, Mass, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today highlighted a new analysis suggesting that the Moderna COVID-19 vaccine is highly effective against circulating variants of concern, including in a v
  Tags：
  The number of readers：872
  Source：
  2021-09-16
• 
  AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
  VANCOUVER, British Columbia & BOSTON--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc.
  Tags：
  The number of readers：1008
  Source：
  2021-09-13
• 
  Know Labs Awarded New Patent for Non-Invasive Diagnostic Tech Platform
  Know Labs Inc, an emerging leader in non-invasive medical diagnostics, has been granted an additional patent for its Bio-RFID technology, growing its substantial patent portfolio to 57 issued and pending patents, an important milestone for the company.
  Tags：
  The number of readers：899
  Source：
  2021-09-10
• 
  GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
  YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa) [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with ha
  Tags：
  The number of readers：1211
  Source：
  2021-08-12
• 
  Blood Vessel Growth Stimulated by Magnetic Fields
  Magnetic fields can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials.
  Tags：
  The number of readers：1148
  Source：
  2021-08-03
• 
  FDA Approves Semglee (insulin glargine-yfgn) as the First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
  Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.
  Tags：
  The number of readers：1264
  Source：
  2021-07-29
• 
  Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
  Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Aristea Therapeutics, Inc. today announced a strategic collaboration to advance the clinical development of RIST4721, an oral CXCR2 antagonist being developed by Aristea for the treatment of palmoplantar pust
  Tags：
  The number of readers：1065
  Source：
  2021-07-28
• 
  Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
  Organon (NYSE: OGN), a global women’s health company and ObsEva (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company dedicated to improving women’s reproductive health, today announced that the companies have entered into an agreement whereby Organ
  Tags：
  The number of readers：1218
  Source：
  2021-07-27
• 
  The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis
  Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the New England Journal of Medicine published results from the Phase 3 HARMONY study, an international, double-blind, placebo-controlled relapse prevention trial in 392 patients evaluating pi
  Tags：
  The number of readers：1168
  Source：
  2021-07-23

Product Info

Product Name

Synonyms

CAS

Molecular Formula Upload

Contact Us

Company

Name

Tel

Email

Details

Submit

• Please fill in product name !
• CAS
• Please fill in your company information correctly!
• Please fill in liaison information correctly!
• Please fill in your telephone number correctly!
• Please fill in your email correctly!
• Please describe the problem of products!